Survival benefit with imatinib mesylate versus interferon-alpha-based regimens in newly diagnosed chronic-phase chronic myelogenous leukemia

1 Citations

Journal

  • Blood

    Blood 108 (6), 1835-1840, 2006

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1572543025491194880
  • NII Article ID
    10021956258
  • Data Source
    • CiNii Articles

Report a problem

Back to top